Best Healthcare Companies in France
The 1319 best Healthcare companies in France in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: ORPEA.
France's Healthcare sector is bigger and more contested than the headline number suggests. We're tracking 1,319 companies here, with $2.6B in total disclosed funding across the board, and this directory ranks them by equity raised and recent funding momentum so you can cut straight to who's moving capital. Nabla leads the pack at $45M, Innate Pharma sits just behind at $43M, and Axoltis Pharma has pulled $21M, which tells you the real action is in pharma and digital health rather than devices. No unicorns yet, but the gap between the top tier and the mid-field is closing fast.
So where's the sector headed? Global healthcare is forecast to reach $2.6T by 2025, up from $2T in 2020, at a 6.3% CAGR driven by virtual touchpoints and tech-reshaped care delivery. Vaccine candidates and immunogenicity trials are the hottest research themes right now, and strict product-safety compliance keeps the regulatory bar high for French entrants. App adoption confirms the momentum: median install growth is running at roughly +16% YoY across 53 healthcare and life-sciences app categories. And as managed care models expand globally, French companies building recurring-revenue health platforms will find the timing useful. Bpifrance and Tikehau Capital are the investors you'll see backing the most credible bets.
- Global Healthcare to Soar Above $2 Trillion in 2020 with Consumerism a
- Healthcare Consumers in Asia-Pacific Prefer a Single Touchpoint
Ranked: Best Healthcare companies in France
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ORPEA Mid term and long term care services for physical and mental dependency. | $442M | 150 mo ago | Public | — | Jean-Claude Marian Founder & Chairman | — | — | — |
| 2 | Juvise Pharmaceuticals Traditional pharma company manufacturing and marketing branded formulations | $417M | 47 mo ago | Funding Raised | 11 | — | WordPressMySQLPHP+15 | 20 patents Oral S1P‑receptor modulator (ponesimod) combination therapies for multiple sclerosis | — |
| 3 | Provepharm Life Solutions Pharmaceutical company dedicated towards the development and valorization of APIs and drug Products | $146M | 57 mo ago | Late Stage | 125 | Michel Feraud CEO | Apple iCloud MailMicrosoft 365Ruby+16 | 100 patents Synthesis of sulfonated triarylmethane dyes and crystalline indocyanine green for pharmaceutical imaging | — |
| 4 | SEVETYS Chain of veterinary clinics | $107M | 48 mo ago | Acquired | 1,000 | Daniel Einhorn CEO | WordPressMySQLPHP+17 | — | — |
| 5 | M2i Life Sciences Provider of APIs, pheromones for crop protection and animal health | $79M | 81 mo ago | Series B | 200 | Bruno Geny Co-Founder | PHPBootstrapXRegExp+6 | — | 1 job opening · 4 launchs · 1 partnership |
| 6 | Domidep Standalone senior living center | $58M | 109 mo ago | Late Stage | 167 | — | WordPressMySQLPHP+13 | — | 3 job openings |
| 7 | Isaltis Company developing and manufacturing high purity mineral salts for a wide range of industries | $55M | 135 mo ago | Acquired | 160 | — | WordPressMySQLPHP+12 | — | — |
| 8 | Almaviva Sante Chains providing medical care, surgical services, and specialized treatment options | $48M | 151 mo ago | Acquired | 4,700 | Bruno Marie CEO | PHPamChartsZURB Foundation+13 | — | 1 job opening · 2 expansions |
| 9 | DELBERT Laboratories Manufacturer of drugs | $47M | 69 mo ago | Series C | 12 | — | — | — | — |
| 10 | QantEv Provider of an AI platform for health and life insurance claims 42AI top 20%Funding top 32%Talent bottom 49%Growth bottom 42% All 7 signals ▾AItop 20% Fundingtop 32% Talentbottom 49% Growthbottom 42% Globalbottom 39% Marketbottom 33% Newsbottom 18% AI: Classified as an AI company Funding: Raised $45.1M · 3 rounds over 6 yrs (0.5/yr) rank vs industry peers · Fliar Intelligence Index 42/100 | $45M | 20 mo ago | Series B | 34 | Hadrien De March Chief Technology Officer And Founder | — | — | 1 award |
| 11 | Nabla Provider of an AI assistant for streamlining clinical documentation workflows 72Moat top 22%AI top 23%Funding top 25%Talent top 28% All 9 signals ▾Moattop 22% AItop 23% Fundingtop 25% Talenttop 28% Growthtop 35% Producttop 40% Techtop 42% Marketbottom 43% Globalbottom 39% Moat: Editorial + unicorn rating 8/10 · Soonicorn AI: Classified as an agentic-AI company · Product described with: artificial intelligence rank vs industry peers · Fliar Intelligence Index 72/100 | $45M | 12 mo ago | Series C | 46 | — | WebflowYouTubeGSAP+17 | — | 1 award |
| 12 | Innate Pharma Developer of antibody based therapeutics to treat cancer 76Fin. health top 17%Patents top 21%Funding top 28%Talent top 28% All 11 signals ▾Fin. healthtop 17% Patentstop 21% Fundingtop 28% Talenttop 28% Innovationtop 32% Markettop 34% Moattop 40% Globaltop 48% Techbottom 49% Growthbottom 47% Newsbottom 47% Fin. health: Revenue ~$62.3M (FY2016) · Net margin 23.3% Patents: 1,175 patents matched (strict assignee match) · 266 filings since 2022 vs 455 in 2017-21 rank vs industry peers · Fliar Intelligence Index 76/100 | $43M | 13 mo ago | Public | 191 | Marc Bonneville Co-Founder | Apple iCloud MailMicrosoft 365Q4+14 | 1,175 patents Engineered antibody and cell therapies targeting immune checkpoints and cancer antigens | — |
| 13 | CILcare Service to develop health products aiming to diagnose, prevent, delay the progression or treat hearing loss… | $42M | 18 mo ago | Series A | 28 | — | WordPressPleskMySQL+24 | — | 1 award |
| 14 | Elivie Provider of home healthcare services | $42M | 107 mo ago | Acquired | 931 | Larbi Hamidi CEO | WordPressApple iCloud MailMicrosoft 365+18 | — | — |
| 15 | Varioptic Optical Technology Provider and Optical Product Manufacturer | $38M | 189 mo ago | Deadpooled | 57 | — | — | 187 patents Variable-focus electrowetting liquid lenses and calibration for imaging systems | — |
| 16 | Kayentis Provider of electronic clinical outcome assessment solutions for clinical trials | $36M | 38 mo ago | Series D | 12 | Philippe Berna Founder | WordPressMySQLPHP+25 | — | 2 job openings · 2 launchs |
| 17 | Biose Provider of therapeutic macrobiotic ranges for human health | $34M | 71 mo ago | Acquired | 2 | — | WordPressMySQLPHP+19 | 14 patents Mucoadhesive vaginal drug delivery systems for sustained antifungal candidiasis treatment | — |
| 18 | biose industrie Developer of drugs based on live microorganisms | $34M | 71 mo ago | Late Stage | 227 | Stanislas Desjonqeères CEO | — | — | — |
| 19 | Novair Designs and manufactures medical gas systems | $30M | 56 mo ago | Series C | 71 | — | SalesforcePHPDebian+14 | 5 patents Optimized rotary valves for PSA oxygen production systems | 1 job opening |
| 20 | happytal Provider of concierge services for hospitals | $28M | 90 mo ago | Acquired | 370 | Pierre Lassarat Co-Founder & CEO | Apple iCloud MailGoogle WorkspaceRuby+19 | — | — |
| 21 | Implicity Cloud and AI-based remote health monitoring solution for providers | $28M | 49 mo ago | Series A | 95 | Arnaud Rosier Co-Founder & CEO | WordPressApple iCloud MailGoogle Workspace+34 | 20 patents Remote cardiac monitoring, data transfer, and AI-driven heart condition prediction | — |
| 22 | Horus Pharma Developer of ophthalmology pharmaceutical products | $25M | 51 mo ago | Series B | 220 | Martine Claret Co-Founder & President | PrestaShopPleskApple iCloud Mail+13 | 117 patents Topical hyaluronic acid/dexpanthenol emulsions and specialized dispensing/packaging systems | 1 award |
| 23 | Biotech Dental Manufacturer of dental implants and other equipment | $24M | 64 mo ago | Acquired | 800 | Philippe Veran Co-founder & President | Cart FunctionalityWordPressTypeScript+31 | 74 patents Dental prosthetic devices and bone regeneration systems for implant dentistry. | 1 award |
| 24 | Oncodesign Services CRO focused on oncology drugs discovery, bioanalysis, and preclinical services | $24M | 28 mo ago | Late Stage | 210 | — | WordPressMySQLPHP+21 | 157 patents Patents concentrated in chemistry & materials | — |
| 25 | Zoi Provider of behavioral healthcare services | $23M | 52 mo ago | Seed | 39 | Paul Dupuy Co-Founder | WordPressMySQLPHP+20 | — | 1 job opening · 1 internship |
| 26 | Axoltis Pharma Diversified pharmaceutical company | $21M | 6 mo ago | Series A | 13 | Yann Godfrin Chief Executive Officer | — | 56 patents Therapeutic peptides for neural repair, synaptic enhancement, and barrier dysfunction treatment | — |
| 27 | Kiro Provider of artificial intelligence development services for healthcare sectors | $18M | 38 mo ago | Series A | 32 | Alexandre Guenoun Co-Founder & CEO | Cart FunctionalityWixSentry+14 | — | 1 partnership · 1 award |
| 28 | Neovacs CDMO focused on manufacturing of vaccines | $18M | 90 mo ago | Public | — | Hugo Brugiere CEO | JoomlaPHPUIKit+11 | 169 patents IL-4/IL-13 cytokine immunotherapies and mRNA vaccine formulations for immune modulation | — |
| 29 | Cure51 Company that provides clinical and molecular database of exceptional cancer survivors | $16M | 26 mo ago | Seed | — | Simon Istolainen Co-Founder | Framer SitesReactMatomo Analytics+11 | — | 1 partnership |
| 30 | Invers Manufacturer of veterinary food products | $15M | 47 mo ago | Series A | 23 | Stephanie Cailloux Managing Director | Cart FunctionalityWooCommerceWordPress+32 | 23 patents Automated insect farming systems: water delivery and tray handling for mass production | — |
| 31 | Home Biosciences Manufacturer of drug research and development for multiple therapeutic areas | $15M | 55 mo ago | Seed | 7 | Magali Richard Co-Founder | — | — | — |
| 32 | Innerskin Medical aesthetic company providing non-invasive treatments for skincare and body contouring | $15M | 6 mo ago | Series B | — | Chrystelle Eid Founder & CEO | Webflow EcommerceCart FunctionalityWebflow+25 | — | 1 expansion |
| 33 | Stane Association focused on healthcare sectors | $11M | 32 mo ago | Series A | — | Mehdi Djelamani Co-Founder | WordPressMySQLPHP+20 | — | 1 partnership |
| 34 | Genoskin In vitro human skin models for preclinical toxicity and efficacy testing | $9M | 9 mo ago | Series A | 39 | Pascal Descargues CEO | WordPressApple iCloud MailGoogle Workspace+29 | 57 patents Ex vivo human skin platforms for inflammation, allergy, vaccine testing, and drug screening | 1 job opening · 2 expansions |
| 35 | ALOGIA Provider of elderly home care services | $7M | 29 mo ago | Series A | 300 | — | WordPressMySQLPHP+21 | — | — |
| 36 | Biophta Developer of a pharmaceutical platform designed to transform ophthalmology by relieving patients from the… | $7M | 24 mo ago | Seed | 3 | Jean Garrec founder & CEO | — | — | — |
| 37 | Injectpower Provider of ultra-miniature batteries enable the development of smart implantable devices and services | $7M | 31 mo ago | Series A | — | Ariel Cao President | — | — | — |
| 38 | Spotlight Medical Precision medicine company addressing the critical issue of inadequate cancer treatments | $7M | 23 mo ago | Seed | — | Gregoire Gessain Co-Founder & CMO | — | — | — |
| 39 | Womed Standalone gynaecology clinic | $6M | 28 mo ago | Series A | — | Gonzague Issenmann Issenmann Co-Founder | WixSentryBootstrap+13 | 14 patents Intrauterine degradable devices for controlled release of hemostatic and therapeutic agents | — |
| 40 | Susu Chain of general clinics | $6M | 30 mo ago | Series A | 22 | Bola Bardet Founder | WebflowSentryYouTube+23 | 2 patents Cleaning systems for sieves and filters in food processing/kitchen equipment | — |
| 41 | Rofim R&D company focused on manufacturing of diagnostic products for multiple therapeutic areas | $6M | 9 mo ago | Series B | 22 | Virgile Omnes Co-Founder | MUIReactReact Router+11 | — | 1 partnership |
| 42 | Generare Provider of drugs discovery services | $5M | 2 mo ago | Series A | — | Vincent Libis Co-Founder | Cart FunctionalitySquarespace CommerceSquarespace+15 | — | 1 job opening |
| 43 | DIANOSIC Manufacturer of ENT care equipment | $5M | 40 mo ago | Series A | 13 | Philippe Bastide Co-Founder & CEO | — | 42 patents Patents concentrated in health & consumer products | — |
| 44 | Oncodesign Provider of preclinical assessment services for anticancer therapies 55Patents top 34%Product top 36%Moat top 40%Market top 42% All 10 signals ▾Patentstop 34% Producttop 36% Moattop 40% Markettop 42% Fundingtop 43% Innovationtop 44% Growthtop 45% Globaltop 49% Techbottom 47% Newsbottom 27% Patents: 157 patents matched (strict assignee match) · 20 filings since 2022 vs 77 in 2017-21 Product: 2 distinct product lines · Company stage: Acquired rank vs industry peers · Fliar Intelligence Index 55/100 | $5M | 3 mo ago | Acquired | 238 | — | WordPressMySQLPHP+24 | 157 patents Macrocyclic small‑molecule kinase inhibitors for RIP2 and LRRK2 therapeutic targets | — |
| 45 | Orakl Oncology Orakl Oncology is a precision oncology start-up that enables the emergence of rare oncology by connecting… | $3M | 18 mo ago | Seed | — | Fanny Jaulin Co-Founder & CEO | SkolengoSentryMariaDB+16 | — | 1 job opening · 2 partnerships · 1 award |
| 46 | Separative Provides preparative HPLC columns for medicinal chemistry and peptides | $3M | 37 mo ago | Funding Raised | 19 | — | — | 12 patents Patents concentrated in transport & manufacturing processes | — |
| 47 | Resolve Stroke Company that specializes in non-invasive stroke diagnosis and aneurysm monitoring using cutting-edge… | $2M | 33 mo ago | Seed | — | Vincent Hingot Co-Founder | — | 5 patents Ultrasound acquisition and processing systems for medical imaging, especially stroke diagnostics. | 1 job opening · 1 internship |
| 48 | Jinko Company that provides supportive care solutions for individuals | $2M | 21 mo ago | Seed | — | Faustine Bouvier Co-Founder & CEO | Webflow EcommerceWebflowSvelte+18 | — | — |
| 49 | MSInsight Provider of operational management services for healthcare industry | $2M | 15 mo ago | Seed | — | Arnaud Cutivet CEO | — | — | 1 internship · 2 awards |
| 50 | Meddenovo Developer of computational biochemistry software for pharmaceutical research and development | $1M | 22 mo ago | Seed | — | Ilke Marion Co-Founder | — | — | — |
Top 12 Healthcare companies in France
#1
Series A · Paris, Ile de France · founded 2022$5.5Mraised▾
Provider of drugs discovery services
- Apr 2026Series A$23.3M
- Oct 2024Seed$5.5M
#2
Series A · Clermont Ferrand, Auvergne Rhone Alpes · founded 2003 · 13 employees$20.9Mraised▾
Diversified pharmaceutical company
- Dec 2025Series A$20.9M
- 2023PE—
#3
Series B · France · founded 2022$14.9Mraised▾
Innerskin is a medical aesthetic company that offers non-invasive skin treatments, including laser hair removal, hydrafacial, and mesotherapy, to rejuvenate and hydrate the skin. The company's services are designed to address various skin concerns, such as sagging skin, loss of volume, and hyperpigmentation. With a focus on delivering personalized care, Innerskin aims to redefine facial harmony and provide patients with a more youthful and radiant appearance.
- Dec 2025Series B$14.9M
#4
Acquired · Dijon, Bourgogne Franche Comte · founded 1995 · 238 employees$4.7Mraised▾
Oncodesign is an oncology preclinical CRO company that provides an assessment of anti-cancer therapies. It has three platforms, PREDICT - conventional in vitro and in vivo pharmacology, Chi-Mice - in vivo chimeric humanized models, and PharmImage - multimodal, non-invasive pharmaco-imaging. It uses Nanocyclix technology, for discovery activity that gives access to potent and selective macrocyclic kinase inhibitors.
- Mar 2026Grant (prize money)$6.9M
- May 2008Series A$4.7M
#5
Series C · Paris, Ile de France · founded 2018 · 46 employees$44.6Mraised▾
Provider of an AI assistant for streamlining clinical documentation workflows. The AI assistant combines ambient artificial intelligence, dictation, and clinical suggestions. It integrates with electronic health record vendors to simplify clinical documentation. The assistant supports clinical documentation in multiple languages and offers note formatting.
- Jun 2025Series C$70M
- Jan 2024Series B$24M
- Apr 2021Series B$20.4M
#6
Public · Marseille, Provence Alpes Cote d Azur · founded 1999 · 191 employees$43.5Mraised▾
Developer of antibody-based therapeutics to treat cancer. The company's portfolio include lacutamab, developed in an advanced form of cutaneous T cell lymphomas and peripheral T cell lymphomas, monalizumab in non-small cell lung cancer, as well as ANKET multi-specific NK cell engagers to address multiple tumor types.
- Apr 2025Post IPO$17.1M
- Jun 2018Grant (prize money)$306.7K
- Jan 2017Post IPO$15M
- Jun 2014Post IPO$68.1M
#7
Series A · Toulouse, Occitanie · founded 2011 · 39 employees$8.8Mraised▾
Genoskin, founded as a spin-off of from the French National Center for Scientific Research (CNRS) and The Paul Sabatier University in Toulouse is engaged in the development of ex vivo human skin models for preclinical efficacy and toxicity testing of potential drug candidates and might help in reducing the use of lab animals. The company claims to keep real human skin tissue alive for 7 days in human skin models and that they are the closest alternative to in vivo clinical testing. The company claims that its human skin collection process is as per the Declaration of Helsinki. The company has a BSL 2 cell culture rooms and 3D imaging technologies. They have proprietary human skin models such as Oncoskin, which can be used to study melanoma and Hyposkin to study subcutaneous injections.
- Sep 2025Series A$5.4M
- Sep 2025Conventional Debt$3.3M
- Aug 2019Grant (prize money)—
- Nov 2018Grant (prize money)$56.9K
#8
Series B · Marseille, Provence Alpes Cote d Azur · founded 2018 · 22 employees$5.8Mraised▾
Provider of a telemedicine platform designed for sharing clinical and patient-related data between doctors, clinics, and patients. The company's platform provides access to clinical description data and medical imaging in real-time, lets users connect to doctors and request health-related information, and features secure exchange and file-sharing tools, enabling doctors to organize and communicate health data and offer medical consultation to patients, anytime, and from anyplace.
- Sep 2025Series B$11.7M
- Oct 2021Series A$5.8M
#9
Series A · Montpellier, Occitanie · founded 2014 · 28 employees$42.3Mraised▾
CILcare is an R&D services company specialised in the development of drug candidates for hearing disorders (tinnitus, hearing loss) and otic disorders (ENT). The company provides preclinical services for research and development related to the hearing disorders area.
- Dec 2024Series A$42.3M
#10
Series B · Paris, Ile de France · 34 employees$45.1Mraised▾
Provider of an AI platform for health and life insurance claims. The platform offers modules for claims management, fraud detection, and data acquisition. It streamlines claims processing, detects fraudulent claims, and ensures data accuracy. The platform also provides tools to capture, clean, enrich, and digitize data from claims documents.
#11
Funding Raised · Lyon, Auvergne Rhone Alpes · founded 2009 · 11 employees$417.3Mraised▾
Juvise Pharmaceuticals is a multinational pharmaceuticals company that currently markets five specialist pharmaceutical products Entumin, Insidon, Lumirelax, Calmixene, and Extovyl. The therapeutic categories covered include psychiatry, rheumatology, ENT & respiratory, and fertility and sexual matters. It also markets two food supplements: Proxeed Plus and Ezerex. These are sold in a total of 35 countries
- Jul 2022Conventional Debt$417.3M
#12
Seed · Villejuif, Ile de France · founded 2023$3.1Mraised▾
Orakl Oncology is a precision oncology start-up that partners with Gustave Roussy, one of the world's top cancer centers, to connect patient tumors and enable the emergence of rare oncology. They have recently raised €3 million to develop their techbio platform for precision oncology.
- Dec 2024Seed$11.6M
- Oct 2023Seed$3.1M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.